Feng Y - Search Results

1

Long-term efficacy and safety of stapokibart for moderate-to-severe atopic dermatitis: 52-week results from a phase 3 trial.

Zhao Y, Zhang L, Wu L, Yang B, Wang J, Li Y, Li J, Diao Q, Sun Q, Zhu X, Man X, Wang L, Li L, Feng Y, Zeng H, Cai T, Ren H, Lu J, Lu Q, Tao X, Xiao R, Ji C, Li F, Zhang J. Zhao Y, et al. Among authors: feng y. Allergy. 2024 Oct 25. doi: 10.1111/all.16368. Online ahead of print. Allergy. 2024. PMID: 39450683

2

[The research on the chemical components of Schizonepeta tenuifolia Briq].

Zhang L, Feng Y, Ding A. Zhang L, et al. Among authors: feng y. Zhong Yao Cai. 2001 Mar;24(3):183-4. Zhong Yao Cai. 2001. PMID: 12587173 Chinese.

3

COPB2: a transport protein with multifaceted roles in cancer development and progression.

Feng Y, Lei X, Zhang L, Wan H, Pan H, Wu J, Zou M, Zhu L, Mi Y. Feng Y, et al. Clin Transl Oncol. 2021 Nov;23(11):2195-2205. doi: 10.1007/s12094-021-02630-9. Epub 2021 Jun 8. Clin Transl Oncol. 2021. PMID: 34101128 Free PMC article. Review.

4

Comprehensive Analysis of 29,464 Cancer Cases and 35,858 Controls to Investigate the Effect of the Cytotoxic T-Lymphocyte Antigen 4 Gene rs231775 A/G Polymorphism on Cancer Risk.

Wan H, Zhou H, Feng Y, Chen Y, Zhu L, Mi Y. Wan H, et al. Among authors: feng y. Front Oncol. 2022 May 4;12:878507. doi: 10.3389/fonc.2022.878507. eCollection 2022. Front Oncol. 2022. PMID: 35600409 Free PMC article.

5

Functions and mechanisms of N6‑methyladenosine in prostate cancer (Review).

Wan H, Feng Y, Wu J, Zhu L, Mi Y. Wan H, et al. Among authors: feng y. Mol Med Rep. 2022 Sep;26(3):280. doi: 10.3892/mmr.2022.12796. Epub 2022 Jul 20. Mol Med Rep. 2022. PMID: 35856412 Free PMC article. Review.

6

Upregulation of COPB2 Promotes Prostate Cancer Proliferation and Invasion Through the MAPK/TGF-β Signaling Pathway.

Feng Y, Sun C, Zhang L, Wan H, Zhou H, Chen Y, Zhu L, Xia G, Mi Y. Feng Y, et al. Front Oncol. 2022 May 6;12:865317. doi: 10.3389/fonc.2022.865317. eCollection 2022. Front Oncol. 2022. PMID: 35600351 Free PMC article.

7

N-glycosylation of GDF15 abolishes its inhibitory effect on EGFR in AR inhibitor-resistant prostate cancer cells.

Wang R, Wen P, Yang G, Feng Y, Mi Y, Wang X, Zhu S, Chen YQ. Wang R, et al. Among authors: feng y. Cell Death Dis. 2022 Jul 19;13(7):626. doi: 10.1038/s41419-022-05090-3. Cell Death Dis. 2022. PMID: 35853851 Free PMC article.

8

Lysine demethylase 5A promotes prostate adenocarcinoma progression by suppressing microRNA-330-3p expression and activating the COPB2/PI3K/AKT axis in an ETS1-dependent manner.

Mi Y, Zhang L, Sun C, Feng Y, Sun J, Wang J, Yang D, Qi X, Wan H, Xia G, Wu S, Zhu L. Mi Y, et al. Among authors: feng y. J Cell Commun Signal. 2022 Dec;16(4):579-599. doi: 10.1007/s12079-022-00671-5. Epub 2022 May 18. J Cell Commun Signal. 2022. PMID: 35581421 Free PMC article.

9

Preoperative resting-state electrophysiological signals predict acute but not chronic postoperative pain.

Han Q, Wang H, Lu X, Li Y, Guo Y, Zhao X, Feng Y, Hu L. Han Q, et al. Among authors: feng y. Eur J Pain. 2024 Nov 23. doi: 10.1002/ejp.4757. Online ahead of print. Eur J Pain. 2024. PMID: 39578949

10

Gender disparities in physical, psychological, and cognitive multimorbidity among elderly hypertensive populations in rural regions.

Miao Y, Zhang J, Wu J, Zhu D, Bai J, Zhang J, Ren R, Guo D, Zhen M, Cui J, Li X, Dong W, Tarimo CS, Feng Y, Shen Z. Miao Y, et al. Among authors: feng y. Int J Equity Health. 2024 Nov 22;23(1):246. doi: 10.1186/s12939-024-02324-y. Int J Equity Health. 2024. PMID: 39578886

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,301 results

Search Page

Filters